Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Venous Thromboembolism in Cancer Patients”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Not applicableStudy completedNCT02502396
What this trial is testing

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Who this might be right for
CancerDeep-vein Thrombosis of the Lower and Upper ExtremitiesPulmonary Embolism+1 more
M.D. Anderson Cancer Center 265
Not applicableStudy completedNCT01803022
What this trial is testing

Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer

Who this might be right for
Venous Thromboembolism
LEO Pharma 419
Not applicableUnknownNCT05229471
What this trial is testing

Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study

Who this might be right for
CancerVenous ThromboembolismRecurrence
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 220
Not applicableActive Not RecruitingNCT03870464
What this trial is testing

LIFE - Lung Cancer, Immunotherapy, Frailty, Effect

Who this might be right for
Non-small Cell Lung CancerQuality of LifeBrain Metastases+1 more
University of Southern Denmark 150
Not applicableStudy completedNCT03114618
What this trial is testing

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient

Who this might be right for
Cancer-associated ThrombosisGenetic Predisposition
Andres muñoz 416
Large-scale testing (Phase 3)Study completedNCT03045406
What this trial is testing

Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer

Who this might be right for
Venous Thromboembolism
Fadoi Foundation, Italy 1,170
Not applicableStudy completedNCT02742623
What this trial is testing

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Who this might be right for
Venous Thrombosis and Pulmonary Embolism
Bayer 528
Not applicableStudy completedNCT04979780
What this trial is testing

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

Who this might be right for
Treatment of Venous Thromboembolism in Cancer PatientsProphylaxis of Recurrent Venous Thromboembolism in Cancer Patients
Bayer 3,708
Not applicableStudy completedNCT03965741
What this trial is testing

Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners

Who this might be right for
Venous Thromboembolism (VTE)
Bayer 97,765
Not applicableUnknownNCT02017743
What this trial is testing

Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Trio Grup Clinical Research 200
Not applicableLooking for participantsNCT06284343
What this trial is testing

The Gynecological Cancer Associated Thrombosis (GynCAT) Study

Who this might be right for
Cancer-associated ThrombosisVenous ThromboembolismGynecologic Cancer+4 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,800
Not applicableStudy completedNCT02922543
What this trial is testing

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Who this might be right for
Multiple Myeloma
Celgene 361
Large-scale testing (Phase 3)Study completedNCT02555878
What this trial is testing

Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 841
Not applicableLooking for participantsNCT06894576
What this trial is testing

Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis

Who this might be right for
Cancer-associated Thrombosis
Ottawa Hospital Research Institute 1,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT07160686
What this trial is testing

Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment

Who this might be right for
Thromboprophylaxis
University of Birmingham 1,456
Not applicableLooking for participantsNCT06714734
What this trial is testing

Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT

Who this might be right for
Venous Thromboembolism
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Post-approval studies (Phase 4)Study completedNCT00966277
What this trial is testing

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Who this might be right for
Pancreatic CancerVenous Thromboembolism
M.D. Anderson Cancer Center 87
Post-approval studies (Phase 4)Study completedNCT04072068
What this trial is testing

Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy

Who this might be right for
ThromboembolismCancer
Gruppo Oncologico Italiano di Ricerca Clinica 150
Large-scale testing (Phase 3)Looking for participantsNCT05920343
What this trial is testing

VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

Who this might be right for
Venous ThromboembolismUrologic Cancer
Ottawa Hospital Research Institute 120
Not applicableStudy completedNCT01602445
What this trial is testing

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep-Vein ThrombosisPulmonary Embolism+1 more
Ottawa Hospital Research Institute 700
Load More Results